Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    September 2017
  1. ZHAO X, Ji Z, Xie Y, Liu G, et al
    MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5992.
    PubMed     Text format     Abstract available


  2. KOU B, Liu W, Xu X, Yang Y, et al
    Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5988.
    PubMed     Text format     Abstract available


  3. HUANG B, Zhang J, Zhang X, Huang C, et al
    Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5959.
    PubMed     Text format     Abstract available


    August 2017
  4. TSUJITA Y, Horiguchi A, Tasaki S, Isono M, et al
    STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Oncol Rep. 2017 Aug 11. doi: 10.3892/or.2017.5902.
    PubMed     Text format     Abstract available


  5. GAO SL, Kong CZ, Zhang Z, Li ZL, et al
    TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5883.
    PubMed     Text format     Abstract available


    July 2017
  6. WANG SC, Wang ST, Liu HT, Wang XY, et al
    Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1survivin downregulation at the late phase of treatment.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5795.
    PubMed     Text format     Abstract available


    June 2017
  7. WANG S, Liu B, Zhang J, Sun W, et al
    Centromere protein U is a potential target for gene therapy of human bladder cancer.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5769.
    PubMed     Text format     Abstract available


  8. WANG H, Zhong J, Wu C, Liu Y, et al
    Stromal antigen 2 functions as a tumor suppressor in bladder cancer cells.
    Oncol Rep. 2017 Jun 12. doi: 10.3892/or.2017.5711.
    PubMed     Text format     Abstract available


  9. RADY M, Mostageer M, Rohde J, Zaghloul A, et al
    Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients.
    Oncol Rep. 2017 Jun 2. doi: 10.3892/or.2017.5695.
    PubMed     Text format     Abstract available


    May 2017
  10. BA M, Cui S, Wang B, Long H, et al
    Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
    Oncol Rep. 2017;37:2761-2770.
    PubMed     Text format     Abstract available


    April 2017
  11. YUAN SY, Shiau MY, Ou YC, Huang YC, et al
    Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5608.
    PubMed     Text format     Abstract available


  12. WU D, Niu X, Tao J, Li P, et al
    MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5607.
    PubMed     Text format     Abstract available


    March 2017
  13. LI W, Liu J, Zou D, Cai X, et al
    Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
    Oncol Rep. 2017;37:1461-1468.
    PubMed     Text format     Abstract available


    January 2017
  14. CHEN JF, Yu BX, Yu R, Ma L, et al
    Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.
    Oncol Rep. 2017 Jan 5. doi: 10.3892/or.2017.5356.
    PubMed     Text format     Abstract available


    December 2016
  15. YU G, Jia Z, Dou Z
    miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Oncol Rep. 2016 Dec 16. doi: 10.3892/or.2016.5326.
    PubMed     Text format     Abstract available


    October 2016
  16. COCCIA A, Mosca L, Puca R, Mangino G, et al
    Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
    Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5150.
    PubMed     Text format     Abstract available


  17. HORI S, Miyake M, Onishi S, Tatsumi Y, et al
    Clinical significance of alpha and betaKlotho in urothelial carcinoma of the bladder.
    Oncol Rep. 2016;36:2117-25.
    PubMed     Text format     Abstract available


    September 2016
  18. KOBAYASHI K, Matsumoto H, Matsuyama H, Fujii N, et al
    Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
    Oncol Rep. 2016 Sep 1. doi: 10.3892/or.2016.5061.
    PubMed     Text format     Abstract available


  19. ZHANG Y, Zhang Z, Li Z, Gong D, et al
    MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.
    Oncol Rep. 2016;36:1293-300.
    PubMed     Text format     Abstract available


    August 2016
  20. SHIN SS, Park SS, Hwang B, Moon B, et al
    MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5052.
    PubMed     Text format     Abstract available


  21. WANG J, Zhao X, Shi J, Pan Y, et al
    miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5040.
    PubMed     Text format     Abstract available


  22. SHIN SS, Park SS, Hwang B, Kim WT, et al
    MicroRNA-106a suppresses proliferation, migration, and invasion of bladder cancer cells by modulating MAPK signaling, cell cycle regulators, and Ets-1-mediated MMP-2 expression.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5015.
    PubMed     Text format     Abstract available


  23. ZHANG N, Bi X, Zeng Y, Zhu Y, et al
    TGF-beta1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
    Oncol Rep. 2016;36:977-83.
    PubMed     Text format     Abstract available


    July 2016
  24. HUANG J, Wang B, Hui K, Zeng J, et al
    miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4940.
    PubMed     Text format     Abstract available


  25. YIN X, Xu C, Zheng X, Yuan H, et al
    SnoN suppresses TGF-beta-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1gamma-dependent manner.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4939.
    PubMed     Text format     Abstract available


  26. YANG X, Zhang F, Luo J, Pang J, et al
    A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
    Oncol Rep. 2016;36:79-89.
    PubMed     Text format     Abstract available


    June 2016
  27. CHUNG YH, Kim D
    RIP kinase-mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin-treated bladder cancer cells.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4895.
    PubMed     Text format     Abstract available


  28. HU KY, Wang G, Liu PF, Cao YW, et al
    Targeting of MCT1 and PFKFB3 influences cell proliferation and apoptosis in bladder cancer by altering the tumor microenvironment.
    Oncol Rep. 2016 Jun 16. doi: 10.3892/or.2016.4884.
    PubMed     Text format     Abstract available


    May 2016
  29. CHEN F, Chen X, Yang D, Che X, et al
    Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4794.
    PubMed     Text format     Abstract available


  30. DENG QF, Sun X, Liang ZF, Zhang ZQ, et al
    Cigarette smoke extract induces the proliferation of normal human urothelial cells through the NF-kappaB pathway.
    Oncol Rep. 2016;35:2665-72.
    PubMed     Text format     Abstract available


    December 2015
  31. KANG M, Ho JN, Kook HR, Lee S, et al
    Theracurmin(R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4537.
    PubMed     Text format     Abstract available


  32. SUN Y, Guan Z, Liang L, Cheng Y, et al
    HIF-1alpha/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4536.
    PubMed     Text format     Abstract available


  33. WANG X, Chen E, Yang X, Wang Y, et al
    5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
    Oncol Rep. 2015 Dec 17. doi: 10.3892/or.2015.4492.
    PubMed     Text format     Abstract available


    November 2015
  34. YOON HY, Kim YJ, Kim JS, Kim YW, et al
    RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.
    Oncol Rep. 2015 Nov 11. doi: 10.3892/or.2015.4409.
    PubMed     Text format     Abstract available


    October 2015
  35. PAN XW, Li L, Huang Y, Huang H, et al
    Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.
    Oncol Rep. 2015 Oct 16. doi: 10.3892/or.2015.4335.
    PubMed     Text format     Abstract available


    September 2015
  36. GAO D, Hu H, Wang Y, Yu W, et al
    CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
    Oncol Rep. 2015 Sep 24. doi: 10.3892/or.2015.4310.
    PubMed     Text format     Abstract available


    August 2015
  37. TAKEUCHI H, Mmeje CO, Jinesh GG, Taoka R, et al
    Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells.
    Oncol Rep. 2015 Aug 21. doi: 10.3892/or.2015.4220.
    PubMed     Text format     Abstract available


    July 2015
  38. PARK SL, Cho TM, Won SY, Song JH, et al
    MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4119.
    PubMed     Text format     Abstract available


  39. LOMBARD AP, Lim RM, Nakagawa RM, Vidallo KD, et al
    Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4117.
    PubMed     Text format     Abstract available


    June 2015
  40. HUANG Y, Zhang SD, McCrudden C, Chan KW, et al
    The prognostic significance of PD-L1 in bladder cancer.
    Oncol Rep. 2015;33:3075-84.
    PubMed     Text format     Abstract available


    May 2015
  41. SUN E, Fan X, Wang L, Lei M, et al
    Recombinant hIFN-alpha2b-BCG inhibits tumor growth in a mouse model of bladder cancer.
    Oncol Rep. 2015 May 18. doi: 10.3892/or.2015.3985.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: